227 completed, 21 unknown, 11 recruiting, 10 withdrawn. 281 Phase 3, 17 Phase 2.
Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis Rupatifen Fumarate Capsules, Rupatadine Fumarate Tablets, Rupatifen Fumarate Capsules Placebo - Seasonal Allergic Rhinitis | Phase 3 | Recruiting | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. | 550 | 2026-08-18 | 2026-09-09 |
| Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis Stapokibart, Placebo - Seasonal Allergic Rhinitis (SAR) | Phase 3 | Recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 136 | 2026-08-13 | 2026-09-03 |
| A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis SHR-1819 Injection, SHR-1819 Injection Placebo - Seasonal Allergic Rhinitis | Phase 3 | Active not recruiting | Guangdong Hengrui Pharmaceutical Co., Ltd | 220 | 2026-08-11 | 2026-10-22 |
| Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063. EP-088_MM09, Placebo - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 250 | 2026-04-15 | 2026-10-29 |
| Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil Administration of investigation of Eurofarma drug, Administration of Comparator - Allergic Rhinitis | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-03-01 | 2025-12-18 | |
| Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063. EP-088_MM09, Placebo - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 250 | 2026-02-24 | 2026-10-29 |
| A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. GR1802 injection, Placebo - Allergic Rhinitis, Seasonal | Phase 3 | Not yet recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 144 | 2025-09-25 | 2025-09-30 |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis PG-011 nasal spray 0.6%(twice daily), Placebo - Seasonal Allergic Rhinitis, SAR | Phase 3 | Not yet recruiting | Prime Gene Therapeutics Co., Ltd. | 600 | 2025-09-15 | 2025-08-28 |
| A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 HDM SLIT-tablet (12 SQ-HDM), Placebo - Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | Completed | ALK-Abelló A/S | 327 | 2025-09-01 | 2026-10-05 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis GR1802 injection, Placebo - Allergic Rhinitis, Seasonal | Phase 3 | Recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2025-08-15 | 2025-09-04 |
| Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab Tezepelumab, Acarizax, Placebo - Severe Asthma, Allergy to House Dust Mites | Phase 3 | Not yet recruiting | University Hospital, Montpellier | 38 | 2025-07-15 | 2025-06-10 |
| Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df Allergen Immunotherapy Extract - Rhinitis, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 736 | 2025-04-02 | 2026-01-16 |
| Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) Chinese Herbal Medicine granules, Placebo - Allergic Rhinitis | Phase 2 / Phase 3 | Recruiting | Chinese University of Hong Kong | 140 | 2025-03-27 | 2026-07-27 |
| Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis Placebo, MG-K10 Humanized Monoclonal Antibody Injection - Seasonal Allergic Rhinitis | Phase 2 / Phase 3 | Recruiting | Shanghai Mabgeek Biotech.Co.Ltd | 160 | 2025-03-20 | 2025-04-18 |
| Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. DEP114, Desloratadine 0.5 MG/ML - Allergic Rhinitis | Phase 3 | Not yet recruiting | EMS | 318 | 2025-02-15 | 2024-02-22 |
| Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine Desloratadine / Betamethasone in fixed dose, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 70 | 2024-11-11 | 2026-07-23 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM) PURETHAL Mites 50,000 AUeq/ml, Biological/Vaccine: Placebo - House Dust Mite Allergy, House Dust Mite Rhinitis | Phase 3 | Completed | HAL Allergy | 691 | 2024-09-09 | 2026-08-10 |
| Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis Product CM9241GRU, Placebo - Rhinitis, Allergic, Perennial | Phase 3 | Unknown | Ache Laboratorios Farmaceuticos S.A. | 432 | 2024-09-01 | 2024-08-29 |
| Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) MAZ-101association, DYMISTA® - Allergic Rhinitis | Phase 3 | Unknown | EMS | 514 | 2024-09-01 | 2024-02-16 |
| Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis LP-003, Placebo - Seasonal Allergic Rhinitis | Phase 3 | Active not recruiting | Longbio Pharma | 546 | 2024-08-01 | 2025-12-26 |
Showing 20 of 281. Sign in to see all of them.
Rhinitis, Allergic, Seasonal (127) · Rhinitis, Allergic, Perennial (82) · Hypersensitivity (23) · Rhinitis (18) · Asthma (14) · Dust Mite Allergy (11) · Conjunctivitis, Allergic (7) · Nasal Obstruction (5) · Rhinorrhea (4) · Sneezing (4) · Conjunctivitis (3) · Chronic Urticaria (2) · Dermatitis, Atopic (2) · Pruritus (2)
Hypersensitivity, Immediate (281) · Otorhinolaryngologic Diseases (281) · Immune System Diseases (280) · Nose Diseases (280) · Respiratory Hypersensitivity (280) · Respiratory Tract Diseases (279) · Rhinitis (263) · Hypersensitivity (258) · Infections (20) · Respiratory Tract Infections (19) · Bronchial Diseases (15) · Lung Diseases (15) · Lung Diseases, Obstructive (15) · Conjunctival Diseases (10)
Mometasone Furoate (31) · azelastine (19) · Fluticasone (16) · desloratadine (15) · montelukast (14) · ciclesonide (13) · Beclomethasone (10) · Loratadine (10) · levocetirizine (8) · Cetirizine (7) · Allergens (5) · Nasal Sprays (5) · MP29-02 (4) · Pseudoephedrine (4) · bilastine (4)
Organon and Co (42) · GlaxoSmithKline (23) · AstraZeneca (14) · Meda Pharmaceuticals (14) · ALK-Abelló A/S (13) · Sumitomo Pharma America, Inc. (10) · Inmunotek S.L. (9) · EMS (7) · Teva Branded Pharmaceutical Products R&D, Inc. (7) · Eurofarma Laboratorios S.A. (5) · Roxall Medizin (5) · UCB Pharma (5) · Glenmark Specialty S.A. (4) · Sandoz (4) · Bayer (3)
United States (85) · China (21) · Germany (21) · Spain (15) · Canada (12) · Poland (12) · South Korea (11) · Brazil (8) · Japan (8) · Italy (7) · Russia (7) · Belgium (6) · Sweden (6) · France (5) · Lithuania (5)
Lewis M Fredane, MD (6) · Sudeesh Tantry, PhD (3) · Annemie Narkus, M.D. (2) · Lewis M. Fredane, MD (2) · Luo Zhang (2) · Sien-hung Yang, Ph.D. (2)
PMID 32926419, PMID 20819318, PMID 21439168, PMID 22737708, PMID 26364765, PMID 29656145, PMID 30027002, PMID 32548677, PMID 34379802, PMID 39035788, PMID 40626378, PMID 12086367, PMID 12100048, PMID 12668793, PMID 14674933, PMID 15049402, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15679739, PMID 15750716, PMID 15898976, PMID 16890769, PMID 16930249, PMID 17619558, PMID 17620075, PMID 17620076, PMID 17651373, PMID 18155284, PMID 18164990, PMID 18331513, PMID 18374405, PMID 18517083, PMID 18517084, PMID 18595980, PMID 18814452, PMID 18946234, PMID 19001265, PMID 19132976, PMID 19230461, PMID 19438584, PMID 19441605, PMID 19441606, PMID 19449366, PMID 19549427, PMID 19624554, PMID 19925886, PMID 19968632, PMID 20434199, PMID 20545698
2015 (3), 2018 (3), 2004 (2), 2023 (2), 2025 (2), 2005 (1), 2008 (1), 2009 (1), 2014 (1), 2016 (1), 2017 (1), 2019 (1)